TG Therapeutics CEO Michael Weiss' 2018 pay jumps 44% to $14M
TG Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
TG Therapeutics reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, two executives at TG Therapeutics received on average a compensation package of $7.7M, a 41% increase compared to previous year.
Average pay of disclosed executives at TG Therapeutics
Michael S. Weiss, Chief Executive Officer, received $14M in total, which increased by 44% compared to 2017. 94% of Weiss' compensation, or $13M, was in stock awards. Weiss also received $155K in non-equity incentive plan and $656K in salary.
For fiscal year 2018, the median employee pay was $113,181 at TG Therapeutics. Therefore, the ratio of Michael S. Weiss' pay to the median employee pay was 126 to one.
Sean A. Power, Chief Financial Officer, received a compensation package of $1.1M, which increased by 7% compared to previous year. 60% of the compensation package, or $641K, was in option awards.
Related executives
You may also like
Source: SEC filing on April 30, 2019.